Keros Therapeutics, Inc. (KROS)
19.39
-0.14
(-0.72%)
USD |
NASDAQ |
Jan 15, 10:48
Keros Therapeutics Other Operating Expenses (Quarterly)
Other Operating Expenses (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Other Operating Expenses (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Other Operating Expenses (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Pfizer Inc. | -- |
| Innoviva, Inc. | -- |
| Ocugen, Inc. | -- |
| Bionano Genomics, Inc. | -- |